Search

everythinglearnresearchcommunity

for

Search:↓

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Balding men had lower bone density, while balding women had higher hip bone density.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Effective treatments for excessive body hair in women include drugs that block androgens, sometimes combined with oral contraceptives.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.

Sex and stress steroids quickly change brain cell structures in the hippocampus.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.